Subscribe to the daily news Sign in
En
10 December 2021

Peli BioThermal Opens India Service Center

Peli BioThermal announces the opening of its latest service center located in India. The new service center is based in Ahmedabad, a major manufacturing hub for pharma companies in the Western part of India.

The new site is a full service network station offering conditioning and refurbishment services for Peli BioThermal’s Crēdo Cargo and Crēdo Xtreme bulk shippers to meet the region’s rising requirement for the company’s Crēdo on Demand rental program.

“This is the latest development of our rapidly expanding Crēdo on Demand rental program,” said Dominic Hyde, Peli BioThermal Vice President – Global Services. “Ahmedabad is a key site where more than eight of India’s largest pharma companies have multiple plants operating, which are all major exporters to markets in Europe and the U.S.

“Our market-leading, high-performing products will be readily available for our customers in the region,” Hyde expands, “which is an area of significant growth for multiple Clinical Research Organisations conducting clinical trials, another area of growth in India. Peli BioThermal’s new India service centre is the latest location in our growing global drop points, service centers and network stations, supporting rental programs to more than 100 locations, as we continue to extensively expand our infrastructure worldwide to better meet the complex needs of our international customers.”

An increasing number of leading pharmaceutical companies are located in Ahmedabad including Astra Zeneca, Swiss Pharma and Torrent Pharma. Served by an international airport, Ahmedabad is an important economic hub where numerous pharma companies have R&D facilities based to introduce new products to the market.                                                                                     

It is estimated the state of Gujarat, where Ahmedabad is located, accounts for approximately 30% of the country’s pharmaceutical production and exports. Within the global pharma market India provides more than 50% of the worldwide requirement for various vaccines and 40% of the demand for generic products in the United States.

Peli BioThermal’s new India facility is its latest in the company’s ongoing plans to add new service centers to support its expanded offerings, growing its already robust and unmatched global network.
Share

Related news

Boosting Eco-Friendly Cold-Chain Solutions for Indian Agriculture
Bihar, a leading horticulture-producing state in East India, faces significant challenges due to its underdeveloped cold-chain infrastructure. These include inadequate packhouses, poor road connect...
03 Jan 2025
Schmitz Cargobull Acquires 48% Stake in GT Trailers
Schmitz Cargobull AG has signed an agreement to acquire a 48% share in GT Trailers, a leading Polish manufacturer of high-volume sets and trailers based in the Opole region. The partnership aim...
12 Mar 2025
Lineage Expands in Western Australia with Fremantle City Coldstores...
Lineage, the world's largest temperature-controlled warehouse REIT listed on NASDAQ as LINE, has announced the acquisition of Fremantle City Coldstores (FCC) in Western Australia. This move strengt...
20 Jan 2025
Schmitz Cargobull Expands Delivery Centre for Refrigerated and Box ...
Schmitz Cargobull has received planning approval to expand its delivery area for refrigerated and box body semi-trailers at its Vreden, Germany site. The project aims to accelerate vehicle deliv...
31 Jan 2025
Sanhua Holding Group Concludes 2025 Annual Operation Plan Conference
On January 23, 2025, Sanhua Holding Group successfully held its 2025 Annual Operation Plan Conference at the Sanhua Xinchang Industrial Park (Meizhu) Conference Center. The hybrid event, attend...
14 Mar 2025
NewCold Doubles Capacity at Lebanon Facility with Major Expansion
NewCold has completed the second phase of its Lebanon, Indiana, warehouse, doubling capacity and transforming it into one of the largest and most advanced cold storage facilities globally. This $30...
04 Mar 2025